CARDURION PHARMA

Serial Number 87122661
Registration 6108164
702

Registration Progress

Application Filed
Aug 1, 2016
Under Examination
Approved for Publication
Published for Opposition
Dec 20, 2016
Registered
Jul 21, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200721)
Due: Jul 21, 2026 202 days

Trademark Image

CARDURION PHARMA

Basic Information

Serial Number
87122661
Registration Number
6108164
Filing Date
August 1, 2016
Registration Date
July 21, 2020
Published for Opposition
December 20, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Nov 19, 2025
Registration
Registered
Classes
042

Rights Holder

Cardurion Pharmaceuticals, Inc.

03
Address
78 Blanchard Road, Suite 200
Burlington, MA 01803

Ownership History

Cardurion Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Cardurion Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Cardurion Pharmaceuticals, Inc.

Original Registrant
03
Burlington, MA

Legal Representation

Attorney
Valerie Brennan

USPTO Deadlines

Next Deadline
202 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200721)
Due Date
July 21, 2026
Grace Period Ends
January 21, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Nov 19, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 19, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 19, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 4, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 21, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 20, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 20, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 20, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 21, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 16, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 15, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 15, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 15, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 15, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 15, 2020 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN Loading...
May 12, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 11, 2020 ALIE A ASSIGNED TO LIE Loading...
May 6, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 6, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
May 6, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 6, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 16, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Mar 3, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 3, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 3, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 3, 2020 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN Loading...
Feb 19, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 11, 2020 IUAF S USE AMENDMENT FILED Loading...
Feb 11, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 9, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 5, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 7, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 11, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 9, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 9, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 9, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 1, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 30, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 30, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 30, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 22, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 20, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 20, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...

Detailed Classifications

Class 042
Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
First Use Anywhere: Aug 1, 2017
First Use in Commerce: Aug 1, 2018

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"